Evidence map›Paper›PMID 27442953›Full record

ReviewBritish journal of haematology2016

Advances in understanding the mechanisms of erythropoiesis in homeostasis and disease.

Raymond Liang, Saghi Ghaffari

Open access · bronzeAbstract readReview
In one paragraph

Review in British journal of haematology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 62 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. Safety and effectiveness of seahorse extract (Journal of advanced veterinary and animal research · 2024
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Erythroid Lineage Cells in the Liver: Novel Immune Regulators and Beyond.Journal of clinical and translational hepatology · 2020
    Review
  15. Review
  16. Apohemoglobin-haptoglobin complex attenuates the pathobiology of circulating acellular hemoglobin and heme.American journal of physiology. Heart and circulatory physiology · 2020
    Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Raymond LiangDepartment of Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Saghi GhaffariDepartment of Developmental & Regenerative Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Icahn School of Medicine at Mount Sinai · US

Funding

Novel Determinants of Terminal Erythroid MaturationR01HL116365 · NHLBI · UNIVERSITY OF WISCONSIN-MADISON · PI BRESNICK, EMERY H, GHAFFARI, SAGHI · 2012 to 2015
$1.6M
NHLBI NIH HHS R01 HL116365
6 · The paper itself

Abstract

Anaemia or decreased blood haemoglobin is the most common blood disorder often characterized by reduced red blood cell (RBC) numbers. RBCs are produced from differentiation and commitment of haematopoietic stem cells to the erythroid lineage by a process called erythropoiesis. Coordination of erythropoietin receptor signalling with several erythroid transcription factors including GATA1 is essential for this process. A number of additional players that are critical for RBC production have been identified in recent years. Major technological advances, such as the development of RNA interference, genetically modified animals, including zebrafish, and imaging flow cytometry have led to these discoveries; the emergence of -omics approaches in combination with the optimization of ex vivo erythroid cultures have also produced a more comprehensive understanding of erythropoiesis. Here we summarize studies describing novel regulators of erythropoiesis that modulate erythroid cell production in the context of human erythroid disorders involving hypoxia, iron regulation, immune-related molecules, and the transcription factor FOXO3.

Indexed as

AnimalsErythroid CellsErythropoiesisForkhead Box Protein O3HomeostasisHumansHypoxiaImmune System DiseasesIronForkhead Box Protein O3Ironerythropoiesishomeostasismechanisms

Identifiers

PMID27442953
PMCPMC6204224
OpenAlexW2480195390

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.